Rivaara Labs

Rivaara Labs is a molecular diagnostics company based in Mumbai, founded in 2019 by Bharat Daftary.

As part of the Bharat Daftary group, Rivaara Labs focuses on delivering automated, sample-to-answer diagnostic solutions for infectious diseases, oncology, and precision medicine. The company aims to be a leading and trusted provider of molecular diagnostics in India, helping doctors and patients achieve timely and accurate clinical outcomes. Rivaara Labs offers a range of services, including pathogen detection, antibiotic resistance testing, and cancer-related genetic testing. Their technology stack features automated RT-PCR solutions, IT connectivity, and LIMS interfaces to provide actionable clinical reports. The company also markets point-of-care solutions for rapid diagnostics and partners with healthcare providers to set up RT-PCR labs. Their product portfolio includes various PCR-based test kits and rapid diagnostic panels for conditions such as respiratory infections, septic blood infections, and tuberculosis. Rivaara Labs primarily serves doctors, hospitals, and healthcare providers in the B2B space.